Crinetics Pharmaceuticals, Inc. (CRNX) Other
Market cap
$7.9B
P/E ratio
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -9.6 | -47 | -40.3 | -46.6 | -43.4 | -28.8 |
| Return on equity (%) |
| 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Return on Assets | -9.6 | -47 | -40.3 | -46.6 | -43.4 | -28.8 |
| Return on equity (%) |